International Faculty
Nishant Agrawal , MD, specializes in the management of patients with benign and malignant tumors of the head and neck. Dr. Agrawal's work has achieved international recognition in the field of head and neck surgical oncology, and head and neck cancer genetics. Under his leadership, a team of researchers completed a landmark study that examined the genome of head and neck squamous cell carcinoma. His group then followed up by publishing the genomic landscapes of the remaining major head and neck cancers, including esophageal squamous cell carcinoma, esophageal adenocarcinoma, medullary thyroid cancer, adenoid cystic carcinoma, and mucoepidermoid carcinoma. Dr. Agrawal then applied these findings to identify tumor DNA as a biomarkers that improve cancer diagnostics in the saliva and plasma of patients with head and neck squamous cell carcinoma. His research is focused on the application of cancer genetics to design diagnostic approaches to reduce morbidity and mortality from head and neck cancer.
In addition to his clinical and research contributions, Dr. Agrawal is an accomplished educator -- teaching medical students, residents, and fellows about the management of patients with head and neck cancer. Prior to joining the University of Chicago, Dr. Agrawal was an associate professor at Johns Hopkins University. He is currently section chief of Otolaryngology - Head and Neck Surgery and director of the Head and Neck Surgical Oncology at the University of Chicago Medicine.
Dr. David Eisele is the Andelot Professor and Director of the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery and Professor of Oncology at the Johns Hopkins Comprehensive Cancer Center.
Dr. Eisele specializes in surgery for malignant and benign tumors of the head and neck, with special interest in salivary gland neoplasms and disorders, including sialendoscopy and other minimally invasive approaches, oral cavity cancers, and oropharyngeal cancers. Dr. Eisele joined Johns Hopkins after having served as Chairman of the Department of Otolaryngology-Head and Neck Surgery at the University of California, San Francisco, where he was the Irwin Mark Jacobs and Joan Klein Jacobs Endowed Chair in Head and Neck Cancer and directed the Head and Neck Oncology Program at the UCSF Comprehensive Cancer Center. Dr. Eisele was previously at Johns Hopkins from 1988 to 2001. Dr. Eisele is Past President of the American Head and Neck Society, a member of the NCCN Head and Neck Cancer Panel, and co-Chair of the NCI Task Force on Rare Tumors. He is a Director of the American Board of Otolaryngology.
Dr Steven Eliades is an assistant professor at the Department of Otorhinolaryngology, Head and Neck Surgery of the University Of Pennsylvania. He graduated from Johns Hopkins University with a B.S. (Biomedical Engineering) in 1999 before completing both his M.D. (Medicine) and Ph.D. (Biomedical Engineering) in 2008.
His clinical expertise are hearing loss, dizziness, Meniere's disease, benign positional vertigo, vertigo, cochlear implants, cholesteatoma, mastoidectomy, otosclerosis, stapedectomy. His research interest are in auditory-vocal integration, central auditory processing, and cochlear implant-related central auditory plasticity. Specifically, he studies how the auditory system processes complex inputs, like speech or vocalization, and how auditory feedback is used during vocal production to control speech/vocal output.
Zhen Gooi, MD, specializes in the care of patients with benign and malignant head and neck tumors. Within the field of head and neck surgery, his clinical interests are microvascular (free flap) reconstruction of the head and neck, and transoral robotic surgery, a minimally invasive treatment approach for selected head and neck tumors that avoids the need for traditional neck, jaw and throat incisions.
Dr. Gooi is the author of numerous peer-reviewed articles and educational videos related to head and neck cancer and reconstruction. He has presented at numerous international conferences and serves as an invited reviewer for the journal Head and Neck. He is currently assistant professor of surgery at the University of Chicago.
Peter Grasso is head of clinical support for MED-EL Business Unit VIBRANT where he is responsible for worldwide technical and medical support for clinics and surgeons of the middle ear implant Vibrant Soundbridge, Bonebridge and ADHEAR. Dr Grasso graduated from the Università di Bologna specializing in bioelectronics, telecommunications and microelectronics.
Professor Xiaoming Huang is director of the Division of Throat / Head and Neck Surgery, Department of Otolaryngology at Sun Yat-sen University in Guangzhou, China. Professor Huang has been conducting researches on diseases such as nasopharyngeal carcinoma and head and neck cancer for years. He is among the first doctors in China to start the minimally invasive surgeries for thyroid adenoma and head related diseases such as salivary gland cancer, congenital neck masses and elongated styloid process. His clinical focus are radical treatment of head and neck cancer, functional operation and minimally invasive surgery, therapy for nasopharyngeal carcinoma, reconstruction of muscle flap defect after surgery for head and neck cancer. He is also interested in endoscopic sinus surgery, endoscopic nasal and skull base surgery, transnasal endoscopic surgery for nose and eye diseases.
Shin-ichi Kanemaru is chief director in Department of Otolaryngology, Head and Neck Surgery at the Medical Research Institute of Kitano Hospital in Osaka, Japan. Named one of the best doctors in Japan since 2010, Professor Kanemaru specializes in surgeries of the middle ear, inner ear, temporal bone and skull base, and his research focuses on regenerative treatments for injuries to the ears, vocal cords and airways.
Jamie A. Ku, MD, is a board-certified Otolaryngology-Head and Neck surgeon in the Cleveland Clinic's Head and Neck Institute and a Staff Member in both the Section of Head and Neck Surgery and Oncology and the Section of Facial Plastic and Reconstructive Surgery. Her clinical expertise is in the surgical treatment of benign and malignant head and neck tumors and complex reconstruction of the head and neck, including microvascular free flaps, to restore form and function after cancer treatment.
After completing her undergraduate degree at Duke University, Dr. Ku earned her medical degree from the University of Pittsburgh School of Medicine in 2010, where she completed a one-year research fellowship in Head and Neck Tumor Molecular Signaling. She completed her post-graduate surgical training in Otolaryngology-Head and Neck Surgery at the Johns Hopkins University in 2015. She then pursued a two-year dual fellowship in advanced Head and Neck Surgical Oncology and Microvascular Reconstructive Surgery at the University of Texas MD Anderson Cancer Center and is certified by the American Head and Neck Society and Advanced Training Council. She also leads the patient-centered outcomes research program in the section of Head and Neck Surgery and Oncology at Cleveland Clinic, focusing on the areas of functional outcomes and quality of life outcomes of the head and neck patients.
Myriam Loyo Li is an assistant professor in the Division of Facial Plastic and Reconstructive Surgery of the Department of Otolaryngology – Head and Neck Surgery at Oregon Health and Science University. She obtained her medical degree from Escuela de Medicina Ignacio A Santos in Mexico before completing her surgical internship and residency at Johns Hopkins Hospital. Dr Li is currently furthering her professional development through a master’s degree program in clinical research focusing on human investigator. Facial nerve injuries including central nervous system imaging and electric stimulation to promote recovery in idiopathic paralysis and patient reported outcomes for rhinoplasty surgery for nasal obstruction are her areas of research. Currently, Dr Li is working on a project which is a pilot study to a randomized control clinical trial to use electric stimulation in the face to promote recovery in patients with poor prognosis for recovery of facial paralysis from Bell’s palsy.
Ryan Li majored in neuroscience at Brown University before obtaining his M.D. at the University of Pittsburg. He completed his residency at Johns Hopkins Hospital and was trained as an instructor at Stanford Hospitals in head and neck surgery and reconstructive surgery. Ryan is currently an assistant professor at Oregon Health and Science University.
Dr. Liu is as an Assistant Professor of Otolaryngology in the Division of Sleep Surgery, and serves as co-director of the Stanford Sleep Surgery Fellowship. He is a committee member of sleep medicine in the American Academy of Otolaryngology. He currently serves on an expert task force directed by the American Academy of Sleep Medicine (AASM) to update surgical guidelines for adult obstructive sleep apnea.
He received his medical and dental degrees from the University of California-San Francisco (UCSF). He was a former Howard Hughes Medical Institute (HHMI) Research Scholar (Cloister Program). After maxillofacial surgery residency at UCSF, Dr. Liu completed his sleep surgery fellowship with the Department of Otolaryngology at Stanford. Dr. Liu practices the full scope of sleep apnea surgery including nasal, palatal, hypoglossal nerve stimulation, genioglossus advancement, distraction osteogenesis maxillary expansion (DOME), and maxillomandibular advancement (MMA). He is also routinely referred patients for orthognathic surgery and facial trauma. In that capacity, he serves as a preceptor to the Stanford Oculoplastic Surgery Fellowship. His active areas of research include dynamic airway examination of OSA, virtual surgical planning for precision facial skeletal surgery, and neuromodulation of the head and neck. He has published over 50 scientific articles and medical texts, with original scientific work on sleep surgery. He lectures extensively in the U.S. and internationally. Dr. Liu is a current Stanford Biodesign Faculty Fellow (2017-18).
Dr Wojciech Krzysztof Mydlarz is director of Head and Neck Surgery - National Capitol Region and assistant professor of Otolaryngology - Head and Neck Surgery at the Johns Hopkins Medicine. His area of expertise includes aerodigestive disorders, carcinoma of the tongue, head and neck cancers, conditions, surgery, tumors, laryngeal cancer, minor salivary gland cancers, oral cancers, oral cavity cancers, oropharynx cancers, robotic thyroid surgery, salivary gland disorders, tumors, sentinel lymph node biopsy, sinonasal Tumors, skin Cancer of the head and neck, skull base surgery, tumors, soft tissue tumors, thyroid cancer, masses, parathyroid, tongue cancer, tonsil cancer, transoral robotic surgery (TORS).
His research interests include surgical and non-surgical treatment outcomes in head and neck cancer patients, molecular biology of head and neck cancer, clinical applications of novel targeted cancer therapies, robotic and laser surgery and their clinical applications, minimally invasive surgical approaches for head and neck cancer.Jeremy Richmon is a fellowship-trained head and neck surgeon who specializes in head and neck cancer and microvascular reconstruction. A 2001 graduate of the University of Rochester School of Medicine, Dr. Richmon completed his residency in otolaryngology at the University of California, San Diego, in 2007, and a clinical fellowship in head/neck oncology, microvascular reconstruction, and skull base surgery at Massachusetts Eye and Ear / Harvard Medical School in 2008. He joined the faculty at Johns Hopkins in 2008 and served as the Director of the Head and Neck Surgery Robotic Program until joining the Massachusetts Eye and Ear Head and Neck Division as a Clinical Associate and the Harvard Medical School faculty in 2016.
Dr. Richmon has become a pioneer in minimally-invasive robotic techniques in the head and neck. He was the first surgeon to perform transoral robotic surgery at Johns Hopkins in 2009 and developed a robust head and neck robotic surgery program of international renown. He has collaborated with engineers and computer scientists to bring the next generation of robotics into the clinical realm and began the robotic thyroid surgery program at Johns Hopkins. Dr. Richmon was also the first surgeon in the United States to perform transoral robotic thyroidectomy, a technique he helped develop. Throughout his career, Dr. Richmon has actively participated in resident and fellow education and has been responsible for the development of residency training curriculums specific to head and neck robotic surgery. He sits on the editorial advisory board for Gland Surgery as well as various national head and neck oncology and reconstructive committees. He has been an invited speaker at national and international meetings and has published more than 100 peer-reviewed papers. Dr. Richmon’s clinical interests include head and neck cancer, skull base surgery, robotic surgery, and microvascular reconstruction of the head and neck. His research interests include microvascular reconstructive techniques of head and neck defects, robotic surgery, and minimally invasive approaches to head and neck problems.
Datuk Dr. Kuljit Singh earned his Master’s in Otorhinolaryngology from University Malaya, Kuala Lumpur in 2002. Prior to that, he served at Hospital Kuala Lumpur & Hospital Kangar, as the ENT Clinical specialist in HKL [2002], Lecturer & ENT Specialist at University Malaya Medical Centre (UMMC) and now Consultant ENT Surgeon at Prince Court Medical Centre (PCMC) since 2007.
An active member in Malaysian Medical Association (MMA) since 1996 and he has contributed and engaged himself in various roles at state and national level of MMA where he also served as the Honorary General Secretary from 2013 – 2014. In terms of networking and foreign collaborations; he has conducted meetings and presented in all the ASEAN countries and has a great networking with all the leading ENT doctors within the region and many other parts of the world. He has served the Malaysian Society of Otorhinolaryngologist [ENT] as President in 2007 and awarded meritorious awards by the society. He leads the way on minimal invasive sinus surgery and recently using Imaging Guidance System in navigating sinus surgery. Currently, he serves the position of Medical Director at PCMC, Kuala Lumpur, Malaysia. His passion is to serve towards the healthcare of the people of this country.David Smith is an assistant professor of the University of Cincinnati’s Department of Otolaryngology, Head & Neck Surgery. His clinical interests are otolaryngology - head and neck surgery, pediatric otolaryngology, sleep medicine, and airway disorders.
Dr Smith obtained his PhD from the University of Virginia in 2005 before completing his M.D. in 2009. He did his residency at Otolaryngology-Head and Neck Surgery in Johns Hopkins Hospital and fellowship in in pediatric Otolaryngology - Head and Neck Surgery and sleep medicine at the Cincinnati Children's Hospital Medical Center.
Bryan Ward is a fellow in neurotology and skull base surgery. He completed residency in otolaryngology - head and neck surgery at Johns Hopkins Hospital and pursued additional training in otology and Eustachian tube procedures at Boston Children’s Hospital with Dr. Dennis Poe. Dr. Ward has a number of research interests in vestibular physiology and pathophysiology, with particular focus on the interactions between strong magnetic fields and the inner ear.
His expertise includes chronic otitis media, ear surgery, Eustachian tube disorders, hearing loss, hearing restoration, Meniere’s disease, superior semicircular canal dehiscence, vestibular disorders and vestibular therapy. Dr Ward’s research interests are vestibular, magnetic fields and superior semicircular canal dehiscence syndrome.
Local Faculty
Dr. Lui obtained her Ph.D. (Hons) training in Molecular Pharmacology at the University of Pittsburgh School of Medicine, USA, followed by post-doctoral trainings at Duke University and University of Pittsburgh, USA. Dr. Lui is devoted to the development of precision medicine for treatment of the upper aerodigestive tract cancers, including head and neck cancers, and nasopharyngeal cancer. Using genomics, proteomics, integrative genomic-proteomic discovery, and a driver mutation screening platform (US patented; co-Inventor), Dr. Lui has contributed to major mutationally-driven drug sensitivity findings in head and neck cancer. As a trained biochemist, Dr. Lui also investigates into the signaling mechanisms selected by mutational events for head and neck cancer tumorigenesis and drug sensitivity. Dr. Lui has obtained research fundings from both the US and the Research Grant Council, Hong Kong, and published over 90 research articles (H-Index=30) in the area of precision medicine, cancer genomics and therapeutics, as well as cancer biology in international and renowned scientific Journals including Cancer Discovery, Nature Communications, JAMA Oncology, PNAS and the Journal of National Cancer Institute, etc.
Dr Iris Ng is an assistant professor at the Department of Otorhinolaryngology, Head and Neck Surgery of The Chinese University of Hong Kong. Dr Ng obtained her Ph.D. degree from The Chinese University of Hong Kong after completing her Master's degree in Audiology from the University of Hong Kong. Ng is currently the chief of the Division of Audiology at the CUHK ORL-HNS department.
Dr Richard Yuxiong Su works as Clinical Associate Professor in Oral & Maxillofacial Surgery, Faculty of Dentistry, University of Hong Kong. He received his undergraduate and postgraduate education and oral & maxillofacial surgery resident training in Sun Yat-sen University, Guangzhou, China. He studied in the Department of Maxillofacial Surgery, University of Luebeck, Germany, in 2009, and the Department of Head and Neck Surgery, MD Anderson Cancer Center, Texas, USA, in 2011-2012. Dr Su specializes and is experienced in the surgical management of oral and maxillofacial benign and malignant tumors, microsurgical reconstruction of head and neck soft tissue and bony defects, and salivary gland diseases including sialendoscopy. He actively participates in clinical and basic research and has published more than 40 manuscripts in peer-review journals.
Dr Tang obtained his medical degree from the University of Hong Kong. He is currently associate consultant in Otorhinolaryngology of the Hospital Authority Kowloon West Cluster and member of the ICU Clinical Service committee at Yan Chai Hospital. Besides publication, Dr Tang is active as course faculty, conference presenter, in delivering public health and school educational talk as well as radio talk show.
